Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of Maternal and Infant Immunization Strategies to Prevent Pneumococcal Disease

Trial Profile

Comparison of Maternal and Infant Immunization Strategies to Prevent Pneumococcal Disease

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Apr 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary) ; Hib vaccine conjugate; Influenza virus vaccine
  • Indications Haemophilus infections; Influenza virus infections; Otitis media; Pneumococcal infections; Respiratory tract infections
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use

Most Recent Events

  • 12 Feb 2012 Results of the neonatal outcome analysis published in the CMAJ: Canadian Medical Association Journal.
  • 22 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 03 May 2011 Results of an analysis following infant vaccination presented at the 2011 Annual Meeting of the Pediatric Academic Societies.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top